Clinical trial
A Prospective, Multicenter, Observational Study Evaluating Serial T-ID Monitoring for the Prevention of CMV Disease and BK Virus-Associated Nephropathy Following Kidney Transplantation
NCT07393594 is registered in ClinicalTrials.gov with Transplant Genomics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Observational Study Evaluating Serial T-ID Monitoring for the Prevention of CMV Disease and BK Virus-Associated Nephropathy Following Kidney Transplantation
- Lead sponsor
- Transplant Genomics, Inc.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- May 19, 2026
- Completion date
- October 30, 2028
- Enrollment
- 1,000 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
bk virus infection, cmv, kidney diseases, kidney injury, ttv virus